BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II
56 results:

  • 1. Prognostic Effect of Preoperative Inflammatory Markers on Morbidity and Overall Survival in Pancreatic Adenocarsinoma.
    Çaparlar MA; Durhan A; Süleymanov M; Binarbaşı C; Koşmaz K
    Niger J Clin Pract; 2023 Dec; 26(12):1902-1909. PubMed ID: 38158359
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. High-Load Gemcitabine Inorganic-Organic Hybrid Nanoparticles as an Image-Guided Tumor-Selective Drug-Delivery System to Treat Pancreatic cancer.
    Ischyropoulou M; Sabljo K; Schneider L; Niemeyer CM; Napp J; Feldmann C; Alves F
    Adv Mater; 2023 Nov; 35(46):e2305151. PubMed ID: 37587542
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Automated Synthesis and Preclinical Evaluation of Optimized Integrin α6-Targeted Positron Emission Tomography Imaging of Pancreatic cancer.
    Chen L; Fu H; He H; Lou K; Li Q; Ye J; Feng G; Yu C
    Mol Pharm; 2023 Aug; 20(8):4277-4284. PubMed ID: 37463487
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. POLQ inhibition elicits an immune response in homologous recombination-deficient pancreatic adenocarcinoma via cGAS/STING signaling.
    Oh G; Wang A; Wang L; Li J; Werba G; Weissinger D; Zhao E; Dhara S; Hernandez RE; Ackermann A; Porcella S; Kalfakakou D; Dolgalev I; Kawaler E; Golan T; Welling TH; Sfeir A; Simeone DM
    J Clin Invest; 2023 Jun; 133(11):. PubMed ID: 36976649
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Yes-Associated Protein 1 Inhibition Induces Immunogenic Cell Death and Synergizes With Radiation and PD-1 Blockade.
    Zhuang Y; Wang Y; Liu C; Li S; Du S; Li G
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):894-905. PubMed ID: 36608830
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. cGAS-STING signaling encourages immune cell overcoming of fibroblast barricades in pancreatic cancer.
    Kabashima A; Matsuo Y; Ito S; Akiyama Y; Ishii T; Shimada S; Masamune A; Tanabe M; Tanaka S
    Sci Rep; 2022 Jun; 12(1):10466. PubMed ID: 35773436
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The STING pathway: Therapeutic vulnerabilities in ovarian cancer.
    Shakfa N; Li D; Nersesian S; Wilson-Sanchez J; Koti M
    Br J Cancer; 2022 Sep; 127(4):603-611. PubMed ID: 35383278
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. DNA-PK Inhibition and Radiation Promote Antitumoral Immunity through RNA Polymerase III in Pancreatic cancer.
    Wang W; McMillan MT; Zhao X; Wang Z; Jiang L; Karnak D; Lima F; Parsels JD; Parsels LA; Lawrence TS; Frankel TL; Morgan MA; Green MD; Zhang Q
    Mol Cancer Res; 2022 Jul; 20(7):1137-1150. PubMed ID: 35348737
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The SETDB1-TRIM28 Complex Suppresses Antitumor Immunity.
    Lin J; Guo D; Liu H; Zhou W; Wang C; Müller I; Kossenkov AV; Drapkin R; Bitler BG; Helin K; Zhang R
    Cancer Immunol Res; 2021 Dec; 9(12):1413-1424. PubMed ID: 34848497
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Synthesis and antiproliferative activity of hindered, chiral 1,2-diaminodiamantane platinum(II) complexes.
    Bakhonsky VV; Pashenko AA; Becker J; Hausmann H; De Groot HJM; Overkleeft HS; Fokin AA; Schreiner PR
    Dalton Trans; 2020 Oct; 49(40):14009-14016. PubMed ID: 33078783
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Automated production of [
    Lindner S; Simmet M; Gildehaus FJ; Jurkschat K; Wängler C; Wängler B; Bartenstein P; Schirrmacher R; Ilhan H
    Nucl Med Biol; 2020; 88-89():86-95. PubMed ID: 32828007
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Imaging of genetically-mediated pancreatitis.
    O'Brien CM; O'Brien AC; Gleeson L; Conlon K; Feeney J; Malone DE
    Clin Imaging; 2020 Sep; 65():113-118. PubMed ID: 32387800
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Ovarian cancer Cells Commonly Exhibit Defective STING Signaling Which Affects Sensitivity to Viral Oncolysis.
    de Queiroz NMGP; Xia T; Konno H; Barber GN
    Mol Cancer Res; 2019 Apr; 17(4):974-986. PubMed ID: 30587523
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Determining the molecular test for indeterminate thyroid nodules best suited for our practice: A quality assurance study.
    Maerki J; Klein M; Chau K; Gimenez C; Fishbein J; Khutti S; Das K
    Diagn Cytopathol; 2019 Apr; 47(4):259-267. PubMed ID: 30488606
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. PDE3 inhibitor and EGCG combination treatment suppress cancer stem cell properties in pancreatic ductal adenocarcinoma.
    Kumazoe M; Takai M; Hiroi S; Takeuchi C; Yamanouchi M; Nojiri T; Onda H; Bae J; Huang Y; Takamatsu K; Yamashita S; Yamada S; Kangawa K; Takahashi T; Tanaka H; Tachibana H
    Sci Rep; 2017 May; 7(1):1917. PubMed ID: 28507327
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Mutational profiling of acute lymphoblastic leukemia with testicular relapse.
    Ding LW; Sun QY; Mayakonda A; Tan KT; Chien W; Lin DC; Jiang YY; Xu L; Garg M; Lao ZT; Lill M; Yang H; Yeoh AE; Koeffler HP
    J Hematol Oncol; 2017 Mar; 10(1):65. PubMed ID: 28253933
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Determining Patient Preferences for Indeterminate Thyroid Nodules: Observation, Surgery or Molecular Tests.
    Lee DJ; Xu JJ; Brown DH; Gilbert RW; Gullane PJ; Irish JC; Rotstein LE; Goldstein DP; de Almeida JR
    World J Surg; 2017 Jun; 41(6):1513-1520. PubMed ID: 28175931
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Nanoscale Coordination Polymers Codeliver Carboplatin and Gemcitabine for Highly Effective Treatment of Platinum-Resistant Ovarian cancer.
    Poon C; Duan X; Chan C; Han W; Lin W
    Mol Pharm; 2016 Nov; 13(11):3665-3675. PubMed ID: 27712076
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. (18)F-nanobody for PET imaging of HER2 overexpressing tumors.
    Xavier C; Blykers A; Vaneycken I; D'Huyvetter M; Heemskerk J; Lahoutte T; Devoogdt N; Caveliers V
    Nucl Med Biol; 2016 Apr; 43(4):247-52. PubMed ID: 27067045
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Self-assembled nanoscale coordination polymers carrying oxaliplatin and gemcitabine for synergistic combination therapy of pancreatic cancer.
    Poon C; He C; Liu D; Lu K; Lin W
    J Control Release; 2015 Mar; 201():90-9. PubMed ID: 25620067
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.